Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Learning at the Rate of Evidence: How AI Is Reshaping R&D at Pfizer

Artificial intelligence (AI) has great potential to transform the timeline from an idea to a medicine or vaccine.

Why Cancer Patients Are Prime Targets for Drug Counterfeiters

All fake drugs pose a risk to public health. For patients living with cancer, though, a mix of intersecting clinical and market dynamics make counterfeit oncology medication especially dangerous — and especially profitable for global criminal trafficking networks.

Set Point Theory: Why the Body Fights to Regain Lost Weight

Obesity is a complex, chronic disease. Managing obesity isn’t just about losing weight—it’s also about keeping it off. That’s a difficult prospect for many, but not because of a lack of discipline. The body is biologically designed to resist sustained weight loss.

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details